ES2831853T3 - Compuestos para tratar los trastornos sensibles a la regulación serotoninérgica controlada por los receptores 5-HT1A - Google Patents

Info

Publication number

ES2831853T3

ES2831853T3 ES17734043T ES17734043T ES2831853T3 ES 2831853 T3 ES2831853 T3 ES 2831853T3 ES 17734043 T ES17734043 T ES 17734043T ES 17734043 T ES17734043 T ES 17734043T ES 2831853 T3 ES2831853 T3 ES 2831853T3

Authority

ES

Spain

Prior art keywords

compound

iib

nmr

mhz

formula

Prior art date

2016-06-24

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Active

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001875 compounds Chemical class 0.000 title claims abstract description 306
• 230000000862 serotonergic effect Effects 0.000 title description 6
• 230000033228 biological regulation Effects 0.000 title description 4
• 102000017911 HTR1A Human genes 0.000 title description 3
• 101150015707 HTR1A gene Proteins 0.000 title description 3
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 22
• 150000003839 salts Chemical class 0.000 claims abstract description 17
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims abstract description 16
• 125000003118 aryl group Chemical group 0.000 claims abstract description 14
• 229910052801 chlorine Inorganic materials 0.000 claims abstract description 9
• 229910052731 fluorine Inorganic materials 0.000 claims abstract description 8
• 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 8
• 125000000592 heterocycloalkyl group Chemical group 0.000 claims abstract description 8
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims abstract description 7
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 7
• 229910052717 sulfur Inorganic materials 0.000 claims abstract description 7
• 229910052760 oxygen Inorganic materials 0.000 claims abstract description 6
• 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 4
• 239000012453 solvate Substances 0.000 claims abstract description 4
• XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims abstract description 3
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 3
• 125000000217 alkyl group Chemical group 0.000 claims abstract 2
• 125000001475 halogen functional group Chemical group 0.000 claims abstract 2
• 238000011282 treatment Methods 0.000 claims description 35
• 230000002265 prevention Effects 0.000 claims description 26
• 239000003814 drug Substances 0.000 claims description 23
• 229940079593 drug Drugs 0.000 claims description 20
• 208000012661 Dyskinesia Diseases 0.000 claims description 14
• 208000024714 major depressive disease Diseases 0.000 claims description 13
• 239000008194 pharmaceutical composition Substances 0.000 claims description 11
• 208000016285 Movement disease Diseases 0.000 claims description 10
• WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims description 8
• WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims description 8
• 230000036506 anxiety Effects 0.000 claims description 7
• 208000019901 Anxiety disease Diseases 0.000 claims description 5
• 239000000969 carrier Substances 0.000 claims description 3
• JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims description 2
• 230000000306 recurrent effect Effects 0.000 claims 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract description 4
• 238000005160 1H NMR spectroscopy Methods 0.000 description 97
• 150000001412 amines Chemical class 0.000 description 77
• -1 cyano, hydroxyl Chemical group 0.000 description 54
• 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 51
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 48
• 239000000203 mixture Substances 0.000 description 43
• 238000004293 19F NMR spectroscopy Methods 0.000 description 23
• 239000007858 starting material Substances 0.000 description 23
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 16
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 16
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 15
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
• OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 14
• 238000002360 preparation method Methods 0.000 description 14
• 102000005962 receptors Human genes 0.000 description 14
• 108020003175 receptors Proteins 0.000 description 14
• 239000000243 solution Substances 0.000 description 14
• 208000035475 disorder Diseases 0.000 description 13
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 12
• 239000000047 product Substances 0.000 description 12
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 10
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
• KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 10
• 239000000556 agonist Substances 0.000 description 10
• WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 10
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
• 239000007787 solid Substances 0.000 description 10
• 238000012360 testing method Methods 0.000 description 10
• 241000700159 Rattus Species 0.000 description 9
• 239000012043 crude product Substances 0.000 description 9
• 230000000694 effects Effects 0.000 description 9
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 8
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 8
• 239000013543 active substance Substances 0.000 description 8
• 238000006243 chemical reaction Methods 0.000 description 8
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 8
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 8
• 235000019341 magnesium sulphate Nutrition 0.000 description 8
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
• 239000012044 organic layer Substances 0.000 description 8
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
• 239000012131 assay buffer Substances 0.000 description 7
• 125000004432 carbon atom Chemical group C* 0.000 description 7
• 239000007788 liquid Substances 0.000 description 7
• 238000000034 method Methods 0.000 description 7
• 238000000746 purification Methods 0.000 description 7
• 239000011541 reaction mixture Substances 0.000 description 7
• 229940076279 serotonin Drugs 0.000 description 7
• 238000003756 stirring Methods 0.000 description 7
• MBTGBRYMJKYYOE-UHFFFAOYSA-N 2,6-difluoropyridine Chemical compound FC1=CC=CC(F)=N1 MBTGBRYMJKYYOE-UHFFFAOYSA-N 0.000 description 6
• 208000020401 Depressive disease Diseases 0.000 description 6
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 230000027455 binding Effects 0.000 description 6
• 238000003818 flash chromatography Methods 0.000 description 6
• 239000010410 layer Substances 0.000 description 6
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
• PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 5
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 5
• XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 5
• 230000000926 neurological effect Effects 0.000 description 5
• 229910052757 nitrogen Inorganic materials 0.000 description 5
• 239000012312 sodium hydride Substances 0.000 description 5
• 229910000104 sodium hydride Inorganic materials 0.000 description 5
• 239000000725 suspension Substances 0.000 description 5
• 230000001225 therapeutic effect Effects 0.000 description 5
• ZZJYIKPMDIWRSN-TZBSWOFLSA-N (+)-butaclamol Chemical compound C12=CC=CC=C2CCC2=CC=CC3=C2[C@@H]1CN1CC[C@@](C(C)(C)C)(O)C[C@@H]13 ZZJYIKPMDIWRSN-TZBSWOFLSA-N 0.000 description 4
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
• 208000020925 Bipolar disease Diseases 0.000 description 4
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 4
• 208000028683 bipolar I disease Diseases 0.000 description 4
• 208000025307 bipolar depression Diseases 0.000 description 4
• 239000003795 chemical substances by application Substances 0.000 description 4
• 239000000460 chlorine Substances 0.000 description 4
• 125000001309 chloro group Chemical group Cl* 0.000 description 4
• 239000002131 composite material Substances 0.000 description 4
• 229960003638 dopamine Drugs 0.000 description 4
• 238000012048 forced swim test Methods 0.000 description 4
• 229910052736 halogen Inorganic materials 0.000 description 4
• 150000002367 halogens Chemical class 0.000 description 4
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
• 239000000543 intermediate Substances 0.000 description 4
• 229960004502 levodopa Drugs 0.000 description 4
• 239000003446 ligand Substances 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 150000007522 mineralic acids Chemical class 0.000 description 4
• 125000001624 naphthyl group Chemical group 0.000 description 4
• 239000003921 oil Substances 0.000 description 4
• 235000019198 oils Nutrition 0.000 description 4
• 150000007524 organic acids Chemical class 0.000 description 4
• PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 4
• 230000002285 radioactive effect Effects 0.000 description 4
• GPTXCAZYUMDUMN-UHFFFAOYSA-N tert-butyl n-(2-hydroxyethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCO GPTXCAZYUMDUMN-UHFFFAOYSA-N 0.000 description 4
• 125000005940 1,4-dioxanyl group Chemical group 0.000 description 3
• UTSSEDORJLCBMS-UHFFFAOYSA-N 2-(3-fluorophenoxy)ethanamine Chemical compound NCCOC1=CC=CC(F)=C1 UTSSEDORJLCBMS-UHFFFAOYSA-N 0.000 description 3
• 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 description 3
• 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• 206010001540 Akathisia Diseases 0.000 description 3
• 206010001541 Akinesia Diseases 0.000 description 3
• 206010003591 Ataxia Diseases 0.000 description 3
• 208000009017 Athetosis Diseases 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• 206010006100 Bradykinesia Diseases 0.000 description 3
• 206010008748 Chorea Diseases 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 208000014094 Dystonic disease Diseases 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 208000006083 Hypokinesia Diseases 0.000 description 3
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 3
• 208000002033 Myoclonus Diseases 0.000 description 3
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
• 208000018737 Parkinson disease Diseases 0.000 description 3
• 239000004743 Polypropylene Substances 0.000 description 3
• 208000001431 Psychomotor Agitation Diseases 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 206010043118 Tardive Dyskinesia Diseases 0.000 description 3
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
• LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 3
• 230000001430 anti-depressive effect Effects 0.000 description 3
• 239000000935 antidepressant agent Substances 0.000 description 3
• 229940005513 antidepressants Drugs 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 229910052799 carbon Inorganic materials 0.000 description 3
• 210000003169 central nervous system Anatomy 0.000 description 3
• 208000012601 choreatic disease Diseases 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 208000010118 dystonia Diseases 0.000 description 3
• 201000006517 essential tremor Diseases 0.000 description 3
• 238000001914 filtration Methods 0.000 description 3
• 125000001153 fluoro group Chemical group F* 0.000 description 3
• 229940093915 gynecological organic acid Drugs 0.000 description 3
• 238000003306 harvesting Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
• 229910052500 inorganic mineral Inorganic materials 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 235000010755 mineral Nutrition 0.000 description 3
• 239000011707 mineral Substances 0.000 description 3
• 125000004433 nitrogen atom Chemical group N* 0.000 description 3
• 230000009871 nonspecific binding Effects 0.000 description 3
• 235000005985 organic acids Nutrition 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 229920001155 polypropylene Polymers 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 235000018102 proteins Nutrition 0.000 description 3
• 102000004169 proteins and genes Human genes 0.000 description 3
• 108090000623 proteins and genes Proteins 0.000 description 3
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 3
• 238000001525 receptor binding assay Methods 0.000 description 3
• 238000009256 replacement therapy Methods 0.000 description 3
• 229920006395 saturated elastomer Polymers 0.000 description 3
• 238000007789 sealing Methods 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 239000012224 working solution Substances 0.000 description 3
• MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 2
• PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 2
• 125000005877 1,4-benzodioxanyl group Chemical group 0.000 description 2
• FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
• NZAXGZYPZGEVBD-UHFFFAOYSA-N 1-benzoylpiperidin-4-one Chemical class C=1C=CC=CC=1C(=O)N1CCC(=O)CC1 NZAXGZYPZGEVBD-UHFFFAOYSA-N 0.000 description 2
• FZXIBIRCACCXGD-UHFFFAOYSA-N 2-(1h-indol-4-yloxy)ethanamine Chemical compound NCCOC1=CC=CC2=C1C=CN2 FZXIBIRCACCXGD-UHFFFAOYSA-N 0.000 description 2
• DJVGKAIINKDIKP-UHFFFAOYSA-N 2-(2,3-dihydro-1,4-benzodioxin-6-yloxy)ethanamine Chemical compound O1CCOC2=CC(OCCN)=CC=C21 DJVGKAIINKDIKP-UHFFFAOYSA-N 0.000 description 2
• HTNHGECAQUCFNW-UHFFFAOYSA-N 2-(2,3-dihydro-1h-indol-4-yloxy)ethanamine Chemical compound NCCOC1=CC=CC2=C1CCN2 HTNHGECAQUCFNW-UHFFFAOYSA-N 0.000 description 2
• HDOCYUANOWIHAQ-UHFFFAOYSA-N 2-(2-aminoethoxy)benzamide Chemical compound NCCOC1=CC=CC=C1C(N)=O HDOCYUANOWIHAQ-UHFFFAOYSA-N 0.000 description 2
• LXOQYJMQPRGSTL-UHFFFAOYSA-N 2-(2-fluorophenoxy)ethanamine Chemical compound NCCOC1=CC=CC=C1F LXOQYJMQPRGSTL-UHFFFAOYSA-N 0.000 description 2
• CKJRKLKVCHMWLV-UHFFFAOYSA-N 2-(2-methoxyphenoxy)ethanamine Chemical compound COC1=CC=CC=C1OCCN CKJRKLKVCHMWLV-UHFFFAOYSA-N 0.000 description 2
• IKIYPTDCNNXUJN-UHFFFAOYSA-N 2-(2-methylsulfanylphenoxy)ethanamine Chemical compound CSC1=CC=CC=C1OCCN IKIYPTDCNNXUJN-UHFFFAOYSA-N 0.000 description 2
• SKLZUIZCCAYHOB-UHFFFAOYSA-N 2-(3-chlorophenoxy)ethanamine Chemical compound NCCOC1=CC=CC(Cl)=C1 SKLZUIZCCAYHOB-UHFFFAOYSA-N 0.000 description 2
• MWOLPDQWBBJNJU-UHFFFAOYSA-N 2-(3-methoxyphenoxy)ethanamine Chemical compound COC1=CC=CC(OCCN)=C1 MWOLPDQWBBJNJU-UHFFFAOYSA-N 0.000 description 2
• USPPRAOYKHROEO-UHFFFAOYSA-N 2-(3-methoxyphenyl)sulfanylethanamine Chemical compound COC1=CC=CC(SCCN)=C1 USPPRAOYKHROEO-UHFFFAOYSA-N 0.000 description 2
• HDXKVIRIUPDMPX-UHFFFAOYSA-N 2-(3-methoxypyridin-2-yl)oxyethanamine Chemical compound COC=1C(=NC=CC=1)OCCN HDXKVIRIUPDMPX-UHFFFAOYSA-N 0.000 description 2
• IGGVZLIHUYNMNQ-UHFFFAOYSA-N 2-(3-methylphenoxy)ethanamine Chemical compound CC1=CC=CC(OCCN)=C1 IGGVZLIHUYNMNQ-UHFFFAOYSA-N 0.000 description 2
• HTMIRIIZZGJJBK-UHFFFAOYSA-N 2-(4-fluorophenoxy)ethanamine Chemical compound NCCOC1=CC=C(F)C=C1 HTMIRIIZZGJJBK-UHFFFAOYSA-N 0.000 description 2
• MBIIVSHFGXEWTH-UHFFFAOYSA-N 2-(4-fluoropyridin-2-yl)oxyethanamine Chemical compound NCCOC1=CC(F)=CC=N1 MBIIVSHFGXEWTH-UHFFFAOYSA-N 0.000 description 2
• YXRCDWIZAGWUBL-UHFFFAOYSA-N 2-(4-methoxyphenoxy)ethanamine Chemical compound COC1=CC=C(OCCN)C=C1 YXRCDWIZAGWUBL-UHFFFAOYSA-N 0.000 description 2
• VTQGEXCRGJRXET-UHFFFAOYSA-N 2-(5-fluoropyridin-2-yl)oxyethanamine Chemical compound NCCOC1=CC=C(F)C=N1 VTQGEXCRGJRXET-UHFFFAOYSA-N 0.000 description 2
• CMMXBLYSQQIRJX-UHFFFAOYSA-N 2-(5-methoxypyridin-2-yl)oxyethanamine Chemical compound COC1=CC=C(OCCN)N=C1 CMMXBLYSQQIRJX-UHFFFAOYSA-N 0.000 description 2
• KUMIOJQXBGJULR-UHFFFAOYSA-N 2-(5-methylpyridin-2-yl)oxyethanamine Chemical compound CC1=CC=C(OCCN)N=C1 KUMIOJQXBGJULR-UHFFFAOYSA-N 0.000 description 2
• MJCVLKDTUBLKRN-UHFFFAOYSA-N 2-(5-methylpyrimidin-2-yl)oxyethanamine Chemical compound CC1=CN=C(OCCN)N=C1 MJCVLKDTUBLKRN-UHFFFAOYSA-N 0.000 description 2
• HGFCHUCSRCHPAB-UHFFFAOYSA-N 2-(6-methoxypyridin-2-yl)oxyethanamine Chemical compound COC1=CC=CC(OCCN)=N1 HGFCHUCSRCHPAB-UHFFFAOYSA-N 0.000 description 2
• AXBFDTTWFGTAQZ-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)oxyethanamine Chemical compound CC1=CC=CC(OCCN)=N1 AXBFDTTWFGTAQZ-UHFFFAOYSA-N 0.000 description 2
• SZPVIOGPECKSPN-UHFFFAOYSA-N 2-[(2,2-dimethyl-3h-1-benzofuran-7-yl)oxy]ethanamine Chemical compound C1=CC(OCCN)=C2OC(C)(C)CC2=C1 SZPVIOGPECKSPN-UHFFFAOYSA-N 0.000 description 2
• SZPFNMHSRXBFCQ-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenoxy]ethanamine Chemical compound NCCOC1=CC=CC(C(F)(F)F)=C1 SZPFNMHSRXBFCQ-UHFFFAOYSA-N 0.000 description 2
• GKYURGOKWNLCBA-UHFFFAOYSA-N 2-[4-(trifluoromethyl)pyridin-2-yl]oxyethanamine Chemical compound NCCOC1=CC(C(F)(F)F)=CC=N1 GKYURGOKWNLCBA-UHFFFAOYSA-N 0.000 description 2
• BCSCHHVCCKWZJP-UHFFFAOYSA-N 2-[6-(trifluoromethyl)pyridin-2-yl]oxyethanamine Chemical compound NCCOC1=CC=CC(C(F)(F)F)=N1 BCSCHHVCCKWZJP-UHFFFAOYSA-N 0.000 description 2
• IMLAIXAZMVDRGA-UHFFFAOYSA-N 2-phenoxyethanamine Chemical compound NCCOC1=CC=CC=C1 IMLAIXAZMVDRGA-UHFFFAOYSA-N 0.000 description 2
• YCBSRVPSWOLVMV-UHFFFAOYSA-N 2-pyridazin-3-yloxyethanamine Chemical compound NCCOC1=CC=CN=N1 YCBSRVPSWOLVMV-UHFFFAOYSA-N 0.000 description 2
• TUVONOFKFDJHBJ-UHFFFAOYSA-N 2-pyridin-2-yloxyethanamine Chemical compound NCCOC1=CC=CC=N1 TUVONOFKFDJHBJ-UHFFFAOYSA-N 0.000 description 2
• QZWULHZPKLFOQL-UHFFFAOYSA-N 2-pyridin-2-ylsulfanylethanamine Chemical compound NCCSC1=CC=CC=N1 QZWULHZPKLFOQL-UHFFFAOYSA-N 0.000 description 2
• WKMLARMIRUVDDF-UHFFFAOYSA-N 2-pyridin-3-yloxyethanamine Chemical compound NCCOC1=CC=CN=C1 WKMLARMIRUVDDF-UHFFFAOYSA-N 0.000 description 2
• YSUKTUWMBAKSSV-UHFFFAOYSA-N 2-pyridin-4-yloxyethanamine Chemical compound NCCOC1=CC=NC=C1 YSUKTUWMBAKSSV-UHFFFAOYSA-N 0.000 description 2
• OUOPDDNPXZHMDY-UHFFFAOYSA-N 2-pyrimidin-2-yloxyethanamine Chemical compound NCCOC1=NC=CC=N1 OUOPDDNPXZHMDY-UHFFFAOYSA-N 0.000 description 2
• KRTFZJAVEOONQI-UHFFFAOYSA-N 2-pyrimidin-4-yloxyethanamine Chemical compound NCCOC1=CC=NC=N1 KRTFZJAVEOONQI-UHFFFAOYSA-N 0.000 description 2
• HEFUVGGDWOENCY-UHFFFAOYSA-N 2-quinolin-8-yloxyethanamine Chemical compound C1=CN=C2C(OCCN)=CC=CC2=C1 HEFUVGGDWOENCY-UHFFFAOYSA-N 0.000 description 2
• AAHCCXXWMBNWAI-UHFFFAOYSA-N 3-(2-aminoethoxy)-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC(OCCN)=C1 AAHCCXXWMBNWAI-UHFFFAOYSA-N 0.000 description 2
• UPVRBJMTIJZXAL-UHFFFAOYSA-N 3-(2-aminoethoxy)benzamide Chemical compound NCCOC1=CC=CC(C(N)=O)=C1 UPVRBJMTIJZXAL-UHFFFAOYSA-N 0.000 description 2
• LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 2
• UGYRJDSEKCYZKI-UHFFFAOYSA-N 3-pyridin-2-ylpropan-1-amine Chemical compound NCCCC1=CC=CC=N1 UGYRJDSEKCYZKI-UHFFFAOYSA-N 0.000 description 2
• JZOOPCSBOXTVMN-UHFFFAOYSA-N 4-(2-aminoethoxy)-1,3-dihydroindol-2-one Chemical compound NCCOC1=CC=CC2=C1CC(=O)N2 JZOOPCSBOXTVMN-UHFFFAOYSA-N 0.000 description 2
• VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 2
• ASXGJMSKWNBENU-UHFFFAOYSA-N 8-OH-DPAT Chemical compound C1=CC(O)=C2CC(N(CCC)CCC)CCC2=C1 ASXGJMSKWNBENU-UHFFFAOYSA-N 0.000 description 2
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
• 102000004980 Dopamine D2 Receptors Human genes 0.000 description 2
• 108090001111 Dopamine D2 Receptors Proteins 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 208000023105 Huntington disease Diseases 0.000 description 2
• 208000002569 Machado-Joseph Disease Diseases 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• UCWSDAHSOCIBPK-UHFFFAOYSA-N N-[3-[2-[[1-(3,4-dichlorobenzoyl)-4-fluoropiperidin-4-yl]methylamino]ethoxy]phenyl]acetamide Chemical compound ClC=1C=C(C(=O)N2CCC(CC2)(F)CNCCOC=2C=C(C=CC=2)NC(C)=O)C=CC=1Cl UCWSDAHSOCIBPK-UHFFFAOYSA-N 0.000 description 2
• YNHCYBQECNBQLO-UHFFFAOYSA-N N-[3-[2-[[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methylamino]ethoxy]phenyl]acetamide Chemical compound ClC=1C=C(C(=O)N2CCC(CC2)(F)CNCCOC=2C=C(C=CC=2)NC(C)=O)C=CC=1F YNHCYBQECNBQLO-UHFFFAOYSA-N 0.000 description 2
• UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 229920002873 Polyethylenimine Polymers 0.000 description 2
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• 208000005793 Restless legs syndrome Diseases 0.000 description 2
• 208000006289 Rett Syndrome Diseases 0.000 description 2
• 208000036834 Spinocerebellar ataxia type 3 Diseases 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
• 208000000323 Tourette Syndrome Diseases 0.000 description 2
• 208000016620 Tourette disease Diseases 0.000 description 2
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
• 208000018839 Wilson disease Diseases 0.000 description 2
• SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 2
• MCPFASWKVQVKGB-UHFFFAOYSA-N [4-[[2-[6-[benzyl(methyl)amino]-5-methylpyridin-2-yl]oxyethylamino]methyl]-4-fluoropiperidin-1-yl]-(3-chloro-4-fluorophenyl)methanone Chemical compound C(C1=CC=CC=C1)N(C1=C(C=CC(=N1)OCCNCC1(CCN(CC1)C(=O)C1=CC(=C(C=C1)F)Cl)F)C)C MCPFASWKVQVKGB-UHFFFAOYSA-N 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• 102000030619 alpha-1 Adrenergic Receptor Human genes 0.000 description 2
• 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 description 2
• 229910021529 ammonia Inorganic materials 0.000 description 2
• 235000019270 ammonium chloride Nutrition 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
• 238000003556 assay Methods 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• QWCRAEMEVRGPNT-UHFFFAOYSA-N buspirone Chemical compound C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 0.000 description 2
• 229960002495 buspirone Drugs 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 239000006285 cell suspension Substances 0.000 description 2
• 229940127271 compound 49 Drugs 0.000 description 2
• HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 239000006185 dispersion Substances 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 150000004677 hydrates Chemical class 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 239000007927 intramuscular injection Substances 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 239000007928 intraperitoneal injection Substances 0.000 description 2
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
• BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
• SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
• AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• WEVYAHXRMPXWCK-UHFFFAOYSA-N methyl cyanide Natural products CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
• TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
• OCIDXARMXNJACB-UHFFFAOYSA-N n'-phenylethane-1,2-diamine Chemical compound NCCNC1=CC=CC=C1 OCIDXARMXNJACB-UHFFFAOYSA-N 0.000 description 2
• TYHXIJJQIJKFSO-UHFFFAOYSA-N n'-pyridin-2-ylethane-1,2-diamine Chemical compound NCCNC1=CC=CC=N1 TYHXIJJQIJKFSO-UHFFFAOYSA-N 0.000 description 2
• UFVPUUQXTLJKAB-UHFFFAOYSA-N n-[3-(2-aminoethoxy)phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(OCCN)=C1 UFVPUUQXTLJKAB-UHFFFAOYSA-N 0.000 description 2
• RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 2
• 239000003176 neuroleptic agent Substances 0.000 description 2
• 230000000701 neuroleptic effect Effects 0.000 description 2
• 238000001543 one-way ANOVA Methods 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• 150000002924 oxiranes Chemical class 0.000 description 2
• 125000004430 oxygen atom Chemical group O* 0.000 description 2
• 239000004031 partial agonist Substances 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical class C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
• 229940044601 receptor agonist Drugs 0.000 description 2
• 239000000018 receptor agonist Substances 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 230000009182 swimming Effects 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• HJQNVUQTARSZDK-UHFFFAOYSA-N tert-butyl n-(3-hydroxyphenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC(O)=C1 HJQNVUQTARSZDK-UHFFFAOYSA-N 0.000 description 2
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
• 125000003944 tolyl group Chemical group 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
• ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 1
• UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
• AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
• ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
• GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
• SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
• GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 1
• IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
• YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 description 1
• YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
• VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 1
• STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
• CBBNQRFXWXBZQP-UHFFFAOYSA-N (3,4-dichlorophenyl)-[4-fluoro-4-[(2-phenoxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1Cl)C(=O)N1CCC(CC1)(CNCCOC1=CC=CC=C1)F CBBNQRFXWXBZQP-UHFFFAOYSA-N 0.000 description 1
• LBGPXUXLKXFCMK-UHFFFAOYSA-N (3,4-dichlorophenyl)-[4-fluoro-4-[(2-pyridin-2-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1Cl)C(=O)N1CCC(CC1)(CNCCOC1=NC=CC=C1)F LBGPXUXLKXFCMK-UHFFFAOYSA-N 0.000 description 1
• SIINLBKMJGQYNO-UHFFFAOYSA-N (3,4-dichlorophenyl)-[4-fluoro-4-[(2-quinolin-8-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound FC1(CNCCOc2cccc3cccnc23)CCN(CC1)C(=O)c1ccc(Cl)c(Cl)c1 SIINLBKMJGQYNO-UHFFFAOYSA-N 0.000 description 1
• WWQYGUPGPQFXAD-UHFFFAOYSA-N (3,4-dichlorophenyl)-[4-fluoro-4-[[2-(2-methoxyphenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1Cl)C(=O)N1CCC(CC1)(CNCCOC1=C(C=CC=C1)OC)F WWQYGUPGPQFXAD-UHFFFAOYSA-N 0.000 description 1
• BJVNWTOKTUJQCC-UHFFFAOYSA-N (3,4-dichlorophenyl)-[4-fluoro-4-[[2-(2-methylsulfanylphenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1Cl)C(=O)N1CCC(CC1)(CNCCOC1=C(C=CC=C1)SC)F BJVNWTOKTUJQCC-UHFFFAOYSA-N 0.000 description 1
• GCGYVRDXSGMVJW-UHFFFAOYSA-N (3,4-dichlorophenyl)-[4-fluoro-4-[[2-(4-methoxyphenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1Cl)C(=O)N1CCC(CC1)(CNCCOC1=CC=C(C=C1)OC)F GCGYVRDXSGMVJW-UHFFFAOYSA-N 0.000 description 1
• NPVINTHTFSBGKQ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-[[2-(3-chlorophenoxy)ethylamino]methyl]-4-fluoropiperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=CC(=CC=C1)Cl NPVINTHTFSBGKQ-UHFFFAOYSA-N 0.000 description 1
• AGPCTQYHDWRNGN-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-[[2-(5-chloropyridin-2-yl)oxyethylamino]methyl]-4-fluoropiperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=NC=C(C=C1)Cl AGPCTQYHDWRNGN-UHFFFAOYSA-N 0.000 description 1
• VTBXTDAXQSIVGY-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-[[2-(6-chloropyridin-2-yl)oxyethylamino]methyl]-4-fluoropiperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=NC(=CC=C1)Cl VTBXTDAXQSIVGY-UHFFFAOYSA-N 0.000 description 1
• BXPJDTCYZQOTIA-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-[[2-[(2,2-dimethyl-3H-1-benzofuran-7-yl)oxy]ethylamino]methyl]-4-fluoropiperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=CC=CC=2CC(OC=21)(C)C BXPJDTCYZQOTIA-UHFFFAOYSA-N 0.000 description 1
• UMTUAIYAQNJXDJ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-[[2-[3-(dimethylamino)phenoxy]ethylamino]methyl]-4-fluoropiperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=CC(=CC=C1)N(C)C UMTUAIYAQNJXDJ-UHFFFAOYSA-N 0.000 description 1
• JNINBXUEJRLSRD-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-[[2-[6-(diethylamino)pyridin-2-yl]oxyethylamino]methyl]-4-fluoropiperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=NC(=CC=C1)N(CC)CC JNINBXUEJRLSRD-UHFFFAOYSA-N 0.000 description 1
• DXWRIDGYFFSIIY-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-phenoxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC=CC=C1)F DXWRIDGYFFSIIY-UHFFFAOYSA-N 0.000 description 1
• PCQQITDIAVWGLB-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyrazin-2-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=CN=C1)F PCQQITDIAVWGLB-UHFFFAOYSA-N 0.000 description 1
• XXKWWMYKJKUXAL-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyridazin-4-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CN=NC=C1)F XXKWWMYKJKUXAL-UHFFFAOYSA-N 0.000 description 1
• ZMEGJWWPDKBOER-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyridin-2-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=CC=C1)F ZMEGJWWPDKBOER-UHFFFAOYSA-N 0.000 description 1
• CJIJWFWCMIPCCS-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyridin-2-ylsulfanylethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCSC1=NC=CC=C1)F CJIJWFWCMIPCCS-UHFFFAOYSA-N 0.000 description 1
• XGRYGIWQWQUCIB-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyridin-3-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC=1C=NC=CC=1)F XGRYGIWQWQUCIB-UHFFFAOYSA-N 0.000 description 1
• PBTAWANUDJJHDQ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyrimidin-2-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=CC=N1)F PBTAWANUDJJHDQ-UHFFFAOYSA-N 0.000 description 1
• OKBXMNPEFPCZNH-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyrimidin-4-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=NC=C1)F OKBXMNPEFPCZNH-UHFFFAOYSA-N 0.000 description 1
• DAUDGFGWHFCRND-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-pyrimidin-5-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC=1C=NC=NC=1)F DAUDGFGWHFCRND-UHFFFAOYSA-N 0.000 description 1
• GQUKVOGAZWDTMK-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(2-quinolin-8-yloxyethylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC=1C=CC=C2C=CC=NC=12)F GQUKVOGAZWDTMK-UHFFFAOYSA-N 0.000 description 1
• MXCJGJFHRSTAIG-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(3-phenylpropylamino)methyl]piperidin-1-yl]methanone Chemical compound Fc1ccc(cc1Cl)C(=O)N1CCC(F)(CNCCCc2ccccc2)CC1 MXCJGJFHRSTAIG-UHFFFAOYSA-N 0.000 description 1
• WPKJQVXIPXZKJQ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[(3-pyridin-2-ylpropylamino)methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCCC1=NC=CC=C1)F WPKJQVXIPXZKJQ-UHFFFAOYSA-N 0.000 description 1
• KOWBAFDEMIDBCY-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(1H-indol-4-yloxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound N1C=CC2=C(C=CC=C12)OCCNCC1(CCN(CC1)C(=O)C1=CC(=C(C=C1)F)Cl)F KOWBAFDEMIDBCY-UHFFFAOYSA-N 0.000 description 1
• FRPYDYUBDGOHLI-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(2-fluorophenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=C(C=CC=C1)F)F FRPYDYUBDGOHLI-UHFFFAOYSA-N 0.000 description 1
• YOAVLBDWCVGCKZ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(2-methoxyphenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=C(C=CC=C1)OC)F YOAVLBDWCVGCKZ-UHFFFAOYSA-N 0.000 description 1
• OLBJQOJHPPLFHK-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(2-methylsulfanylphenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound CSc1ccccc1OCCNCC1(F)CCN(CC1)C(=O)c1ccc(F)c(Cl)c1 OLBJQOJHPPLFHK-UHFFFAOYSA-N 0.000 description 1
• WZKXISBZTZAMNX-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(3-methoxyphenyl)sulfanylethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCSC1=CC(=CC=C1)OC)F WZKXISBZTZAMNX-UHFFFAOYSA-N 0.000 description 1
• WOMMHANJCVMKAZ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(3-methoxypyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=CC=C1OC)F WOMMHANJCVMKAZ-UHFFFAOYSA-N 0.000 description 1
• JGPDBMBAXJTZAM-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(3-methylphenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC=1C=C(C=CC=1)C)F JGPDBMBAXJTZAM-UHFFFAOYSA-N 0.000 description 1
• UVGOPVMDNYVNOI-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(4-fluorophenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC=C(C=C1)F)F UVGOPVMDNYVNOI-UHFFFAOYSA-N 0.000 description 1
• VGNJZLFABGNCBA-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(4-fluoropyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=CC(=C1)F)F VGNJZLFABGNCBA-UHFFFAOYSA-N 0.000 description 1
• RPMCBOIGGLBGEL-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(4-methoxyphenoxy)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC=C(C=C1)OC)F RPMCBOIGGLBGEL-UHFFFAOYSA-N 0.000 description 1
• ZWIZEAIJEJNAJL-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(4-methoxypyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=CC(=C1)OC)F ZWIZEAIJEJNAJL-UHFFFAOYSA-N 0.000 description 1
• TYIREBTWRRZFOA-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(5-methoxypyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=C(C=C1)OC)F TYIREBTWRRZFOA-UHFFFAOYSA-N 0.000 description 1
• LMUCVWASWOAHCM-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(5-methylpyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=C(C=C1)C)F LMUCVWASWOAHCM-UHFFFAOYSA-N 0.000 description 1
• BLJZKXJVIGQCID-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(5-methylpyrimidin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=C(C=N1)C)F BLJZKXJVIGQCID-UHFFFAOYSA-N 0.000 description 1
• MTUKCGFMNKPJRX-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(6-fluoropyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC(=CC=C1)F)F MTUKCGFMNKPJRX-UHFFFAOYSA-N 0.000 description 1
• CPHQONPXXQJSEU-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(6-methoxypyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC(=CC=C1)OC)F CPHQONPXXQJSEU-UHFFFAOYSA-N 0.000 description 1
• HPYBDVNCBKPJOQ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(6-methylpyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=NC(=CC=C1)C HPYBDVNCBKPJOQ-UHFFFAOYSA-N 0.000 description 1
• UIHFTURLRBENJM-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(6-pyrazol-1-ylpyridin-2-yl)oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound N1(N=CC=C1)C1=CC=CC(=N1)OCCNCC1(CCN(CC1)C(=O)C1=CC(=C(C=C1)F)Cl)F UIHFTURLRBENJM-UHFFFAOYSA-N 0.000 description 1
• RPOKNYKEZIGQTQ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-(pyridin-2-ylamino)ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCNC1=NC=CC=C1)F RPOKNYKEZIGQTQ-UHFFFAOYSA-N 0.000 description 1
• GKXSCSYAOOOLAP-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-[2-(methylamino)phenoxy]ethylamino]methyl]piperidin-1-yl]methanone Chemical compound CNc1ccccc1OCCNCC1(F)CCN(CC1)C(=O)c1ccc(F)c(Cl)c1 GKXSCSYAOOOLAP-UHFFFAOYSA-N 0.000 description 1
• BMEHLDKQUOMXTR-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-[3-(trifluoromethyl)phenoxy]ethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC(=CC=C1)C(F)(F)F)F BMEHLDKQUOMXTR-UHFFFAOYSA-N 0.000 description 1
• JKMPOCIHFLMQKZ-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-[4-(trifluoromethyl)pyridin-2-yl]oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC=CC(=C1)C(F)(F)F)F JKMPOCIHFLMQKZ-UHFFFAOYSA-N 0.000 description 1
• ZFFPDESUEYNSGC-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-[5-methyl-6-(methylamino)pyridin-2-yl]oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound CNc1nc(OCCNCC2(F)CCN(CC2)C(=O)c2ccc(F)c(Cl)c2)ccc1C ZFFPDESUEYNSGC-UHFFFAOYSA-N 0.000 description 1
• GPCOZCFGTRWRLE-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[2-[6-(methylamino)pyridin-2-yl]oxyethylamino]methyl]piperidin-1-yl]methanone Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=NC(=CC=C1)NC)F GPCOZCFGTRWRLE-UHFFFAOYSA-N 0.000 description 1
• QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
• IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
• UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
• OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 1
• HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
• YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
• IOQORVDNYPOZPL-VQTJNVASSA-N (5S,6R)-5-(4-chlorophenyl)-6-cyclopropyl-3-[6-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]-5,6-dihydro-2H-1,2,4-oxadiazine Chemical compound ClC1=CC=C(C=C1)[C@@H]1NC(=NO[C@@H]1C1CC1)C1=NC(=C(C=C1)N1C=NC(=C1)C)OC IOQORVDNYPOZPL-VQTJNVASSA-N 0.000 description 1
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
• MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• SRKGZXIJDGWVAI-GVAVTCRGSA-M (e,3r)-7-[6-tert-butyl-4-(4-fluorophenyl)-2-propan-2-ylpyridin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CC(C)C1=NC(C(C)(C)C)=CC(C=2C=CC(F)=CC=2)=C1\C=C\C(O)C[C@@H](O)CC([O-])=O SRKGZXIJDGWVAI-GVAVTCRGSA-M 0.000 description 1
• KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical group C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 description 1
• JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
• CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical compound C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
• KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
• BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
• SILNNFMWIMZVEQ-UHFFFAOYSA-N 1,3-dihydrobenzimidazol-2-one Chemical compound C1=CC=C2NC(O)=NC2=C1 SILNNFMWIMZVEQ-UHFFFAOYSA-N 0.000 description 1
• KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
• JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 description 1
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
• RXJJNDRFJSCULJ-UHFFFAOYSA-N 1-(3,4-dichlorobenzoyl)piperidin-4-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C(=O)N1CCC(=O)CC1 RXJJNDRFJSCULJ-UHFFFAOYSA-N 0.000 description 1
• FODGPXWJTNUVJU-UHFFFAOYSA-N 1-(3-chloro-4-fluorobenzoyl)piperidin-4-one Chemical compound C1=C(Cl)C(F)=CC=C1C(=O)N1CCC(=O)CC1 FODGPXWJTNUVJU-UHFFFAOYSA-N 0.000 description 1
• MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 description 1
• KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
• WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
• ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
• UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
• XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
• QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
• HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
• BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
• VHVUTJZQFZBIRR-UHFFFAOYSA-N 1h-pyridazin-4-one Chemical compound OC1=CC=NN=C1 VHVUTJZQFZBIRR-UHFFFAOYSA-N 0.000 description 1
• WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
• DUKUTTINODXDJP-UHFFFAOYSA-N 2,6-difluoro-3-methylpyridine Chemical compound CC1=CC=C(F)N=C1F DUKUTTINODXDJP-UHFFFAOYSA-N 0.000 description 1
• FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 1
• HSLSHKDEXOUFHX-UHFFFAOYSA-N 2-(2-aminoethoxy)-n-methylaniline Chemical compound CNC1=CC=CC=C1OCCN HSLSHKDEXOUFHX-UHFFFAOYSA-N 0.000 description 1
• BQXKVWPRCVTEKI-UHFFFAOYSA-N 2-(4-methoxypyridin-2-yl)oxyethanamine Chemical compound COC1=CC(=NC=C1)OCCN BQXKVWPRCVTEKI-UHFFFAOYSA-N 0.000 description 1
• OMYXVLLKCYDQNC-UHFFFAOYSA-N 2-(6-fluoropyridin-2-yl)oxyethanamine hydrochloride Chemical compound Cl.NCCOc1cccc(F)n1 OMYXVLLKCYDQNC-UHFFFAOYSA-N 0.000 description 1
• JHKKTXXMAQLGJB-UHFFFAOYSA-N 2-(methylamino)phenol Chemical compound CNC1=CC=CC=C1O JHKKTXXMAQLGJB-UHFFFAOYSA-N 0.000 description 1
• WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
• XJNDSYKFCJSPON-UHFFFAOYSA-N 2-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]-2-hydroxyacetonitrile Chemical compound C1CC(C(C#N)O)(F)CCN1C(=O)C1=CC=C(F)C(Cl)=C1 XJNDSYKFCJSPON-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
• FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
• VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
• YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
• TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
• WGFCNCNTGOFBBF-UHFFFAOYSA-N 2-bromopyrazine Chemical compound BrC1=CN=CC=N1 WGFCNCNTGOFBBF-UHFFFAOYSA-N 0.000 description 1
• ILAHVONGWYINEB-UHFFFAOYSA-N 2-fluoro-4-methoxypyridine Chemical compound COC1=CC=NC(F)=C1 ILAHVONGWYINEB-UHFFFAOYSA-N 0.000 description 1
• UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
• LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
• 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
• NOTUSWLXPWJIDF-UHFFFAOYSA-N 2-pyrazin-2-yloxyethanamine hydrochloride Chemical compound Cl.NCCOc1cnccn1 NOTUSWLXPWJIDF-UHFFFAOYSA-N 0.000 description 1
• AEIBPLFIASUDSX-UHFFFAOYSA-N 2-pyridazin-4-yloxyethanamine hydrochloride Chemical compound Cl.NCCOc1ccnnc1 AEIBPLFIASUDSX-UHFFFAOYSA-N 0.000 description 1
• PQFJWCLRJDFGGK-UHFFFAOYSA-N 2-pyrimidin-5-yloxyethanamine hydrochloride Chemical compound Cl.NCCOc1cncnc1 PQFJWCLRJDFGGK-UHFFFAOYSA-N 0.000 description 1
• VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
• MPTQIQDZNNKURZ-UHFFFAOYSA-N 3-(2-aminoethoxy)-N-methylaniline Chemical compound NCCOC=1C=C(NC)C=CC=1 MPTQIQDZNNKURZ-UHFFFAOYSA-N 0.000 description 1
• QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• DLZUHSFUBZTBQZ-UHFFFAOYSA-N 3-chloro-4-fluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1Cl DLZUHSFUBZTBQZ-UHFFFAOYSA-N 0.000 description 1
• WZBRELLUDUPCFZ-UHFFFAOYSA-N 4-[2-[[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methylamino]ethoxy]-1,3-dihydroindol-2-one Chemical compound ClC=1C=C(C(=O)N2CCC(CC2)(F)CNCCOC2=C3CC(NC3=CC=C2)=O)C=CC=1F WZBRELLUDUPCFZ-UHFFFAOYSA-N 0.000 description 1
• WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
• DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 1
• NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
• XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 1
• OPHKAHVILUWFTD-UHFFFAOYSA-N 6-(2-aminoethoxy)-N,N-dimethylpyridin-2-amine Chemical compound NCCOC1=CC=CC(=N1)N(C)C OPHKAHVILUWFTD-UHFFFAOYSA-N 0.000 description 1
• VBSSAMXRWHDTFA-UHFFFAOYSA-N 6-(2-aminoethoxy)-N-benzyl-N,3-dimethylpyridin-2-amine hydrochloride Chemical compound Cl.CN(Cc1ccccc1)c1nc(OCCN)ccc1C VBSSAMXRWHDTFA-UHFFFAOYSA-N 0.000 description 1
• ARYXUZJGHTWGOZ-UHFFFAOYSA-N 6-(2-aminoethoxy)-N-benzyl-N-methylpyridin-2-amine hydrochloride Chemical compound Cl.CN(Cc1ccccc1)c1cccc(OCCN)n1 ARYXUZJGHTWGOZ-UHFFFAOYSA-N 0.000 description 1
• SPDWGCUJZHTXPL-UHFFFAOYSA-N 6-(2-aminoethoxy)-N-methylpyridin-2-amine Chemical compound NCCOC1=CC=CC(=N1)NC SPDWGCUJZHTXPL-UHFFFAOYSA-N 0.000 description 1
• SAVZTCISLPZMKK-UHFFFAOYSA-N 6-(3,4-dichlorobenzoyl)-1-oxa-6-azaspiro[2.5]octane-2-carbonitrile Chemical compound ClC=1C=C(C(=O)N2CCC3(C(O3)C#N)CC2)C=CC=1Cl SAVZTCISLPZMKK-UHFFFAOYSA-N 0.000 description 1
• MOKQWCBSDJFHJI-UHFFFAOYSA-N 6-(3-chloro-4-fluorobenzoyl)-1-oxa-6-azaspiro[2.5]octane-2-carbonitrile Chemical compound C1=C(Cl)C(F)=CC=C1C(=O)N1CCC2(C(O2)C#N)CC1 MOKQWCBSDJFHJI-UHFFFAOYSA-N 0.000 description 1
• RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 1
• USAJMRIOONMYNR-UHFFFAOYSA-N 6-fluoro-n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC(F)=N1 USAJMRIOONMYNR-UHFFFAOYSA-N 0.000 description 1
• MJZXZUBWFMNZGN-UHFFFAOYSA-N 6-fluoro-n-methylpyridin-2-amine Chemical compound CNC1=CC=CC(F)=N1 MJZXZUBWFMNZGN-UHFFFAOYSA-N 0.000 description 1
• UZALKVXCOUSWSL-UHFFFAOYSA-N 6-fluoropyridin-2-amine Chemical compound NC1=CC=CC(F)=N1 UZALKVXCOUSWSL-UHFFFAOYSA-N 0.000 description 1
• HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 1
• 108060003345 Adrenergic Receptor Proteins 0.000 description 1
• 102000017910 Adrenergic receptor Human genes 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 102000007371 Ataxin-3 Human genes 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 1
• PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 1
• 208000009132 Catalepsy Diseases 0.000 description 1
• KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
• BZPOPHHMWUCUHD-UHFFFAOYSA-N ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCNC1=CC=CC=C1)F Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCNC1=CC=CC=C1)F BZPOPHHMWUCUHD-UHFFFAOYSA-N 0.000 description 1
• NFYQCOMGMFYPLZ-UHFFFAOYSA-N ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC(=CC=C1)F)F Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC(=CC=C1)F)F NFYQCOMGMFYPLZ-UHFFFAOYSA-N 0.000 description 1
• QLLXKLMQMYRBID-UHFFFAOYSA-N ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC(=CC=C1)OC)F Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC(=CC=C1)OC)F QLLXKLMQMYRBID-UHFFFAOYSA-N 0.000 description 1
• LYZQHJQVCAOUAB-UHFFFAOYSA-N ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC=NC=C1)F Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC1=CC=NC=C1)F LYZQHJQVCAOUAB-UHFFFAOYSA-N 0.000 description 1
• BSGIOERWRQXNEX-UHFFFAOYSA-N ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC=1N=NC=CC=1)F Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(CNCCOC=1N=NC=CC=1)F BSGIOERWRQXNEX-UHFFFAOYSA-N 0.000 description 1
• JZCAGBINSPHSNG-UHFFFAOYSA-N ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=NC(=CC=C1)N(C)C Chemical compound ClC=1C=C(C=CC=1F)C(=O)N1CCC(CC1)(F)CNCCOC1=NC(=CC=C1)N(C)C JZCAGBINSPHSNG-UHFFFAOYSA-N 0.000 description 1
• 229940126657 Compound 17 Drugs 0.000 description 1
• 229940126639 Compound 33 Drugs 0.000 description 1
• 229940127007 Compound 39 Drugs 0.000 description 1
• RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
• 101150049660 DRD2 gene Proteins 0.000 description 1
• 238000003476 Darzens condensation reaction Methods 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 108091000058 GTP-Binding Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
• YBSNGQYPRXFFSY-UHFFFAOYSA-N N-[6-(2-aminoethoxy)pyridin-2-yl]acetamide Chemical compound NCCOC1=CC=CC(=N1)NC(C)=O YBSNGQYPRXFFSY-UHFFFAOYSA-N 0.000 description 1
• YKPPYFOYDVMTKO-UHFFFAOYSA-N N-[6-[2-[[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methylamino]ethoxy]pyridin-2-yl]acetamide Chemical compound ClC=1C=C(C(=O)N2CCC(CC2)(F)CNCCOC2=CC=CC(=N2)NC(C)=O)C=CC=1F YKPPYFOYDVMTKO-UHFFFAOYSA-N 0.000 description 1
• OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• PCKPVGOLPKLUHR-UHFFFAOYSA-N OH-Indolxyl Natural products C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 description 1
• 235000019502 Orange oil Nutrition 0.000 description 1
• ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
• AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
• 206010047853 Waxy flexibility Diseases 0.000 description 1
• LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
• MXZNUGFCDVAXLG-CHWSQXEVSA-N [(2S)-1-[(2R)-3-methyl-2-(pyridine-4-carbonylamino)butanoyl]pyrrolidin-2-yl]boronic acid Chemical compound CC(C)[C@@H](NC(=O)c1ccncc1)C(=O)N1CCC[C@@H]1B(O)O MXZNUGFCDVAXLG-CHWSQXEVSA-N 0.000 description 1
• PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
• HEBLUYZFQWNRJW-UHFFFAOYSA-N [4-[[2-[6-[benzyl(methyl)amino]pyridin-2-yl]oxyethylamino]methyl]-4-fluoropiperidin-1-yl]-(3-chloro-4-fluorophenyl)methanone Chemical compound C(C1=CC=CC=C1)N(C1=CC=CC(=N1)OCCNCC1(CCN(CC1)C(=O)C1=CC(=C(C=C1)F)Cl)F)C HEBLUYZFQWNRJW-UHFFFAOYSA-N 0.000 description 1
• SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000000172 allergic effect Effects 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000008503 anti depressant like effect Effects 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
• PKZXLMVXBZICTF-UHFFFAOYSA-N befiradol Chemical compound N1=CC(C)=CC=C1CNCC1(F)CCN(C(=O)C=2C=C(Cl)C(F)=CC=2)CC1 PKZXLMVXBZICTF-UHFFFAOYSA-N 0.000 description 1
• 229950007200 befiradol Drugs 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
• 229940092714 benzenesulfonic acid Drugs 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
• 239000004067 bulking agent Substances 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 229960003563 calcium carbonate Drugs 0.000 description 1
• XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
• 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 229940125773 compound 10 Drugs 0.000 description 1
• 229940125797 compound 12 Drugs 0.000 description 1
• 229940126543 compound 14 Drugs 0.000 description 1
• 229940125758 compound 15 Drugs 0.000 description 1
• 229940126142 compound 16 Drugs 0.000 description 1
• 229940125782 compound 2 Drugs 0.000 description 1
• 229940125810 compound 20 Drugs 0.000 description 1
• 229940126086 compound 21 Drugs 0.000 description 1
• 229940126208 compound 22 Drugs 0.000 description 1
• 229940125833 compound 23 Drugs 0.000 description 1
• 229940125961 compound 24 Drugs 0.000 description 1
• 229940125846 compound 25 Drugs 0.000 description 1
• 229940125851 compound 27 Drugs 0.000 description 1
• 229940127204 compound 29 Drugs 0.000 description 1
• 229940126214 compound 3 Drugs 0.000 description 1
• 229940125877 compound 31 Drugs 0.000 description 1
• 229940125878 compound 36 Drugs 0.000 description 1
• 229940125807 compound 37 Drugs 0.000 description 1
• 229940127573 compound 38 Drugs 0.000 description 1
• 229940126540 compound 41 Drugs 0.000 description 1
• 229940125936 compound 42 Drugs 0.000 description 1
• 229940125844 compound 46 Drugs 0.000 description 1
• 229940125898 compound 5 Drugs 0.000 description 1
• 229940126545 compound 53 Drugs 0.000 description 1
• 229940127113 compound 57 Drugs 0.000 description 1
• 229940125900 compound 59 Drugs 0.000 description 1
• 229940126179 compound 72 Drugs 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 235000019700 dicalcium phosphate Nutrition 0.000 description 1
• 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 229910001873 dinitrogen Inorganic materials 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 239000003651 drinking water Substances 0.000 description 1
• 235000020188 drinking water Nutrition 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 239000003480 eluent Substances 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000000706 filtrate Substances 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 239000000174 gluconic acid Substances 0.000 description 1
• 235000012208 gluconic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
• 125000005843 halogen group Chemical group 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 150000002430 hydrocarbons Chemical group 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
• 229960004801 imipramine Drugs 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000002198 insoluble material Substances 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 108010024941 iodothyronine deiodinase type II Proteins 0.000 description 1
• 229910000358 iron sulfate Inorganic materials 0.000 description 1
• 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
• BYXYCUABYHCYLY-UHFFFAOYSA-N isoindole-1,3-dione;potassium Chemical compound [K].C1=CC=C2C(=O)NC(=O)C2=C1 BYXYCUABYHCYLY-UHFFFAOYSA-N 0.000 description 1
• ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
• ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 229960000448 lactic acid Drugs 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 229960001375 lactose Drugs 0.000 description 1
• 238000000670 ligand binding assay Methods 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 238000005461 lubrication Methods 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 229940098895 maleic acid Drugs 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 229940099690 malic acid Drugs 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 230000000873 masking effect Effects 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
• GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 239000002808 molecular sieve Substances 0.000 description 1
• TYJSZNSMFKWJTR-UHFFFAOYSA-N n-(6-fluoropyridin-2-yl)acetamide Chemical compound CC(=O)NC1=CC=CC(F)=N1 TYJSZNSMFKWJTR-UHFFFAOYSA-N 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 1
• 239000010502 orange oil Substances 0.000 description 1
• AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 229960002296 paroxetine Drugs 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 230000000079 pharmacotherapeutic effect Effects 0.000 description 1
• MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 1
• 229960001999 phentolamine Drugs 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 238000010149 post-hoc-test Methods 0.000 description 1
• 230000036544 posture Effects 0.000 description 1
• 229910000027 potassium carbonate Inorganic materials 0.000 description 1
• LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
• WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• GRJJQCWNZGRKAU-UHFFFAOYSA-N pyridin-1-ium;fluoride Chemical compound F.C1=CC=NC=C1 GRJJQCWNZGRKAU-UHFFFAOYSA-N 0.000 description 1
• 150000003222 pyridines Chemical class 0.000 description 1
• LTXJLQINBYSQFU-UHFFFAOYSA-N pyrimidin-5-ol Chemical compound OC1=CN=CN=C1 LTXJLQINBYSQFU-UHFFFAOYSA-N 0.000 description 1
• JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 1
• 238000007142 ring opening reaction Methods 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 239000003723 serotonin 1A agonist Substances 0.000 description 1
• 239000000952 serotonin receptor agonist Substances 0.000 description 1
• 238000010898 silica gel chromatography Methods 0.000 description 1
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
• 229940080313 sodium starch Drugs 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 229940032147 starch Drugs 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 239000011550 stock solution Substances 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 229960004793 sucrose Drugs 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• CEIJFEGBUDEYSX-FZDBZEDMSA-N tandospirone Chemical compound O=C([C@@H]1[C@H]2CC[C@H](C2)[C@@H]1C1=O)N1CCCCN(CC1)CCN1C1=NC=CC=N1 CEIJFEGBUDEYSX-FZDBZEDMSA-N 0.000 description 1
• 229950000505 tandospirone Drugs 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• BLDQEEPGDVRCQC-UHFFFAOYSA-N tert-butyl 2-amino-3-bromopropanoate Chemical compound CC(C)(C)OC(=O)C(N)CBr BLDQEEPGDVRCQC-UHFFFAOYSA-N 0.000 description 1
• 238000010998 test method Methods 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• 238000010257 thawing Methods 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 125000001544 thienyl group Chemical group 0.000 description 1
• 229930192474 thiophene Natural products 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 150000003852 triazoles Chemical class 0.000 description 1
• IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
• 230000002747 voluntary effect Effects 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1
• 125000005023 xylyl group Chemical group 0.000 description 1